Update on Paraneoplastic Neurologic Disorders

被引:11
作者
Rosenfeld, Myrna R. [1 ]
Dalmau, Josep [1 ]
机构
[1] Univ Penn, Dept Neurol, Div Neurooncol, Philadelphia, PA 19104 USA
关键词
Paraneoplastic; Neurologic; Autoimmunity; CANCER-ASSOCIATED RETINOPATHY; EATON-MYASTHENIC-SYNDROME; CELL LUNG-CANCER; UVEAL MELANOCYTIC PROLIFERATION; MELANOMA-ASSOCIATED RETINOPATHY; OPSOCLONUS-MYOCLONUS SYNDROME; NMDA-RECEPTOR ENCEPHALITIS; GUILLAIN-BARRE-SYNDROME; CENTRAL-NERVOUS-SYSTEM; STIFF-PERSON-SYNDROME;
D O I
10.1634/theoncologist.2010-0001
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
When patients with cancer develop neurologic symptoms, common causes include metastasis, infections, coagulopathy, metabolic or nutritional disturbances, and neurotoxicity from treatments. A thorough clinical history, temporal association with cancer therapies, and results of ancillary tests usually reveal one of these mechanisms as the etiology. When no etiology is identified, the diagnosis considered is often that of a paraneoplastic neurologic disorder (PND). With the recognition that PNDs are more frequent than previously thought, the availability of diagnostic tests, and the fact that, for some PNDs, treatment helps, PNDs should no longer be considered diagnostic zebras, and when appropriate should be included in the differential diagnosis early in the evaluation. The Oncologist 2010;15:603-617
引用
收藏
页码:603 / 617
页数:15
相关论文
共 123 条
[1]
Albert ML, 2000, ANN NEUROL, V47, P9
[2]
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates [J].
Ances, BM ;
Vitaliani, R ;
Taylor, RA ;
Liebeskind, DS ;
Voloschin, A ;
Houghton, DJ ;
Galetta, SL ;
Dichter, M ;
Alavi, A ;
Rosenfeld, MR ;
Dalmau, J .
BRAIN, 2005, 128 :1764-1777
[3]
Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies [J].
Antoine, JC ;
Mosnier, JF ;
Absi, L ;
Convers, P ;
Honnorat, J ;
Michel, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (01) :7-14
[4]
Paraneoplastic disorders of the central nervous system: Update on diagnostic criteria and treatment [J].
Bataller, L ;
Dalmau, JO .
SEMINARS IN NEUROLOGY, 2004, 24 (04) :461-471
[5]
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus [J].
Bataller, L ;
Graus, F ;
Saiz, A ;
Vilchez, JJ .
BRAIN, 2001, 124 :437-443
[6]
Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer [J].
Bataller, L ;
Wade, DF ;
Graus, F ;
Stacey, HD ;
Rosenfeld, MR ;
Dalmau, J .
NEUROLOGY, 2004, 62 (05) :778-782
[7]
Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy [J].
Bazhin, Alexandr V. ;
Dalke, Claudia ;
Willner, Nadine ;
Abschuetz, Oliver ;
Wildberger, Hannes G. H. ;
Philippov, Pavel P. ;
Dummer, Reinhard ;
Graw, Jochen ;
de Angelis, Martin Hrabe ;
Schadendorf, Dirk ;
Umansky, Viktor ;
Eichmueller, Stefan B. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (01) :140-149
[8]
BenDavid Y, 1996, CANCER-AM CANCER SOC, V78, P2153
[9]
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis [J].
Bernal, F ;
Graus, F ;
Pifarré, A ;
Saiz, A ;
Benyahia, B ;
Ribalta, T .
ACTA NEUROPATHOLOGICA, 2002, 103 (05) :509-515
[10]
Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders [J].
Blaes, F ;
Strittmatter, M ;
Merkelbach, S ;
Jost, V ;
Klotz, M ;
Schimrigk, K ;
Hamann, GF .
JOURNAL OF NEUROLOGY, 1999, 246 (04) :299-303